NEWS
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
Monogram Technologies Inc. (NASDAQ:MGRM) has announced a strategic collaboration with Shalby (NSE:SHALBY) to conduct a multicenter clinical trial for its mBȏs TKA System. Shalby, the world's largest orthopedic hospital chain, will enroll patients at various sites in India to evaluate the system's safety and effectiveness. This collaboration follows Monogram's recent 510(k) submission to the FDA, which has passed the Administrative Review.
Key points:
Shalby performs over 14,000 annual knee replacement surgeries globally
The Indian TKA market size is approximately 200,000 per year, growing at a 20% CAGR
The trial will use Consensus CKS implants, equivalent to Monogram's mPress implants
Post-trial, Monogram may transfer a robot to Shalby's hospital system
Both companies see potential for expanded collaboration and global market opportunities
Key points:
Shalby performs over 14,000 annual knee replacement surgeries globally
The Indian TKA market size is approximately 200,000 per year, growing at a 20% CAGR
The trial will use Consensus CKS implants, equivalent to Monogram's mPress implants
Post-trial, Monogram may transfer a robot to Shalby's hospital system
Both companies see potential for expanded collaboration and global market opportunities
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2605Followers
107Following
28KVisitors
Follow